Capital Flow Monitor · Sponsors · CIK 1795091
OS Therapies Inc
115 Pullman Crossing Road, Grasonville, MD, 21638 · 410-297-7793
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$4.2M
Sold
$4.2M
% sold
100.0%
Investors
27
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-16 | D | 506(b) | $9.3M | $1.6M | 17.3% | 1 | EDGAR ↗ |
| 2026-03-06 | D | 506(b) | $2.0M | $2.0M | 100.0% | 9 | EDGAR ↗ |
| 2026-01-20 | D | 506(b) | $7.5M | $3.5M | 46.5% | 9 | EDGAR ↗ |
| 2025-09-10 | D | 506(b) | $3.8M | $3.8M | 100.0% | 10 | EDGAR ↗ |
| 2025-07-16 | D ·current | 506(b) | $4.2M | $4.2M | 100.0% | 27 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Paul A. Romness — Executive Officer / Director, Grasonville, MD
- Robert G. Petit — Executive Officer, Grasonville, MD
- Christopher P. Acevedo — Executive Officer, Grasonville, MD
- John Ciccio — Director, Grasonville, MD
- Avril McKean Dieser — Director, Grasonville, MD
- Karim Galzahr — Director, Grasonville, MD
- Olivier Jarry — Director, Grasonville, MD
- Theodore F. Search — Director, Grasonville, MD
Placement agents
- Ceros Financial Services, Inc. · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.